98.73
price up icon1.38%   1.295
 
loading

Merck Co Inc Azioni (MRK) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
7.83%
15,775.00
14,630.00 15,962.00 15,035.00 14,487.00
Cost Of Revenue
9.51%
3,540.00
3,912.00 4,264.00 4,024.00 3,926.00
Gross Profit
14.15%
12,235.00
10,718.00 11,698.00 11,011.00 10,561.00
Operating Expenses
48.57%
6,565.00
12,764.00 6,078.00 16,346.00 6,911.00
Interest Income/Expense
2.26%
303.00
310.00 317.00 277.00 242.00
Benefits Costs and Expenses
39.40%
10,105.00
16,676.00 10,342.00 20,370.00 10,837.00
Costs And Expenses
39.40%
10,105.00
16,676.00 10,342.00 20,370.00 10,837.00
Operating Income/Loss
377.13%
5,670.00
-2,046.00 5,620.00 -5,335.00 3,650.00
Income/Loss From Continuing Operations Before Tax
377.13%
5,670.00
-2,046.00 5,620.00 -5,335.00 3,650.00
Income Tax Expense/Benefit, Deferred
94.52%
-51.00
-931.00 -336.00 -355.00 -277.00
Income Tax Expense/Benefit
210.12%
903.00
-820.00 870.00 637.00 825.00
Income/Loss From Continuing Operations After Tax
488.83%
4,767.00
-1,226.00 4,750.00 -5,972.00 2,825.00
Net Income/Loss
488.83%
4,767.00
-1,226.00 4,750.00 -5,972.00 2,825.00
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
5.00
- 5.00 3.00 -4.00
Basic Average Shares
253.40K%
2,533.00
-1.00 2,537.00 2,539.00 2,538.00
Diluted Average Shares
127.30K%
2,544.00
-2.00 2,546.00 2,539.00 2,551.00
Basic Earnings Per Share
483.67%
1.88
-0.49 1.87 -2.35 1.11
Diluted Earnings Per Share
489.58%
1.87
-0.48 1.86 -2.35 1.11
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
drug_manufacturers_general NVS
$103.35
price down icon 0.20%
$167.80
price up icon 0.93%
$286.05
price down icon 0.09%
drug_manufacturers_general JNJ
$153.48
price up icon 0.15%
drug_manufacturers_general PFE
$24.93
price up icon 0.01%
Capitalizzazione:     |  Volume (24 ore):